Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

828 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic factors in conversion surgery following nab-paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual-center study.
Igarashi T, Yamada S, Hoshino Y, Murotani K, Baba H, Takami H, Yoshioka I, Shibuya K, Kodera Y, Fujii T. Igarashi T, et al. Among authors: takami h. Ann Gastroenterol Surg. 2022 Aug 16;7(1):157-166. doi: 10.1002/ags3.12613. eCollection 2023 Jan. Ann Gastroenterol Surg. 2022. PMID: 36643365 Free PMC article.
The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy.
Obata Y, Kanda M, Shimizu D, Takami H, Inokawa Y, Hattori N, Hayashi M, Tanaka C, Nakayama G, Kodera Y. Obata Y, et al. Among authors: takami h. Surg Today. 2023 Aug;53(8):964-972. doi: 10.1007/s00595-023-02658-0. Epub 2023 Feb 16. Surg Today. 2023. PMID: 36797438
High Preoperative Platelet to Lymphocyte Ratio Is Associated with a Greater Risk of Postoperative Complications and Hematogenous Recurrences in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Treatment.
Sasahara M, Kanda M, Shimizu D, Takami H, Inokawa Y, Hattori N, Hayashi M, Tanaka C, Fujiwara M, Nakayama G, Kodera Y. Sasahara M, et al. Among authors: takami h. Dig Surg. 2023;40(1-2):48-57. doi: 10.1159/000530018. Epub 2023 Mar 9. Dig Surg. 2023. PMID: 36893749
Albumin-Globulin Ratio Indicates the Survival Outcome of Pancreatic Cancer Cases Who Underwent Preoperative Treatment and Curative Surgical Resection.
Hayashi M, Kobayashi D, Takami H, Inokawa Y, Tanaka N, Kurimoto K, Nakanishi K, Umeda S, Shimizu D, Hattori N, Kanda M, Tanaka C, Nakayama G, Kodera Y. Hayashi M, et al. Among authors: takami h. Nutr Cancer. 2023;75(5):1330-1339. doi: 10.1080/01635581.2023.2191384. Epub 2023 Mar 24. Nutr Cancer. 2023. PMID: 36961102
828 results